P21 Peptide

P21 is a synthetic small-molecule peptide analog extensively used in pre-clinical research to investigate CNTF-like neurotrophic effects, brain-derived neurotrophic factor (BDNF) upregulation, tau hyperphosphorylation inhibition, and adult hippocampal neurogenesis. This research-grade peptide is produced under stringent GMP-compliant conditions and provided as a lyophilized powder to ensure superior purity, stability, and reliability in experimental applications.

Engineered solely for preclinical investigations, each batch of P21 undergoes a comprehensive quality assessment and includes complete documentation, including a Certificate of Analysis (COA), purity data, and structural verification.

Scientific Overview

P21 functions as a CNTF-derived mimetic that influences neurotrophic pathways without the immunogenicity or side effects of full-length CNTF in research settings. Preclinical investigations demonstrate P21’s potential effects in the following areas:

• Enhancement of dentate gyrus neurogenesis and maturation of newborn neurons
• Upregulation of BDNF expression and synaptic plasticity markers
• Modulation of GSK-3β activity to reduce tau hyperphosphorylation
• Investigation of cognitive and mnemonic endpoints in preclinical rodent models
• Influence on neuronal survival and dendritic/synaptic integrity in disease models

Why Researchers Choose Our P21

For laboratories requiring dependable P21 research peptide, our manufacturing process prioritizes reproducibility and scientific precision. Every batch is confirmed for:

• Purity and structural identity
• Consistent performance in research applications
• Rigorous production controls and full documentation
• Accessible pricing within the research community

Research-Referenced Functional Attributes (Based on existing preclinical and literature data—not intended as claims of therapeutic use)

• Promotion of neurogenesis and maturation in the dentate gyrus granular and subgranular zones in rodent models
• Increase in BDNF levels leading to synaptic protein expression enhancement
• Inhibition of tau hyperphosphorylation through GSK-3β pathway modulation
• Support for investigations into cognitive and neuronal plasticity endpoints in preclinical models
• Potential rescue of synaptic deficits in transgenic neurodegeneration models
• Examination of oral bioavailability and blood-brain barrier permeability in long-term studies

For Research Use Only. Not for human use.